H43.2 Crystalline deposits in vitreous body

Name of the Condition

• Crystalline Deposits in Vitreous Body

Summary

Crystalline deposits in the vitreous body involve the presence of crystalline material within the vitreous gel, the clear substance filling the eye. This condition may affect vision depending on the size, number, and location of the deposits.

Causes

Crystalline deposits can form due to metabolic disorders, inflammation, or degenerative changes in the eye. They may also result from systemic conditions affecting ocular tissues.

Risk Factors

• Age-related changes in the vitreous.
• Underlying metabolic or inflammatory conditions.
• Previous ocular surgeries or trauma.

Symptoms

• Visual disturbances such as floaters or blurred vision.
• Possible glare or reduced visual clarity.
• Symptoms may be mild or asymptomatic in some cases.

Diagnosis

A comprehensive eye examination, including slit-lamp biomicroscopy and fundoscopy, is used to identify crystalline deposits. Imaging studies like ultrasound or optical coherence tomography (OCT) may be employed if the retina is obscured.

Treatment Options

• Observation: For asymptomatic or mild cases.
• Medications: To address underlying causes, if applicable.
• Surgical Intervention: Vitrectomy may be considered for severe or vision-impairing deposits.

Prognosis and Follow-Up

Prognosis depends on the underlying cause and severity of deposits. Regular follow-up is recommended to monitor for progression or associated complications.

Complications

• Vision impairment if deposits are extensive.
• Potential for retinal detachment in rare cases.
• Secondary inflammation or infection.

Lifestyle & Prevention

• Maintain regular eye examinations.
• Manage systemic conditions that may contribute to ocular changes.
• Protect eyes from trauma or injury.

When to Seek Professional Help

Seek care if experiencing sudden changes in vision, increased floaters, or persistent visual disturbances.

Tips for Medical Coders

Document the presence and characteristics of crystalline deposits, including location and impact on vision. Ensure clinical correlation with underlying conditions when applicable. Use H43.2 for crystalline deposits in the vitreous body.